BioSpace News Archive

Medical Sensors Market To Reach Valuation Of US$ 32.15 Bn By 2028, increasing incidences of chronic disorders to drive the market

According to the report, the global medical sensors market was valued at US$ 15.23 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028.

March 22, 2022
·
6 min read
Human Growth Hormone Treatment & Drugs Market is reaching nearly US$ 4.8 Billion by 2032 from US$ 3.4 Billion in 2021 – Future Market Insights

DUBAI, United Arab Emirates, The Human Growth Hormone Treatment & Drugs Market was valued at US$ 3.4 billion in 2021, and it is predicted to expand to US$ 4.8 billion by 2032, with a compound annual growth rate of 3.3% from 2022 to 2032.

March 22, 2022
·
6 min read
Vaginal Slings Market to be worth US$ 2,533.0 Mn By 2026, Rise In Prevalence Of Urinary Incontinence to drive the market

Albany NY, United States: Transparency Market Research has published a new report titled ‘Vaginal Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global vaginal slings market was valued at US$ 1,676.0 Mn in 2017.

March 22, 2022
·
5 min read
Patient Engagement Platforms Market is Projected to Reach Nearly US$ 93.4 Billion by 2032 – Future Market Insights

DUBAI, United Arab Emirates, The global Patient Engagement Platforms Market was worth USD 16.6 billion in 2021, and it is predicted to increase at a CAGR of 17% throughout the forecast period.

March 22, 2022
·
7 min read
Biotech Bay

Molecular Matrix, Inc. Announces Full Commercial Launch of Osteo-P® Synthetic Bone Graft Substitute

Molecular Matrix, Inc. (MMI), a leader in regenerative medicine polymer technology, is proud to announce the full launch of its Osteo-P® Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system.

March 22, 2022
·
2 min read
Policy

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

March 22, 2022
·
11 min read
Drug Development

Cipher Pharmaceuticals Announces Partner, Moberg Pharma’s Regulatory Submission to FDA for North American Phase 3 Study

Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company”) today announced that the Company’s partner, Moberg Pharma AB, (“Moberg Pharma”) has submitted a regulatory filing for the next clinical Phase 3 study for MOB-015 (nail fungus treatment) to the U.S. Food and Drug Administration (“FDA”).

March 22, 2022
·
8 min read
Genetown

Imbria Pharmaceuticals to Participate at SVB Leerink Biopharma Private Company Connect

Imbria Pharmaceuticals, Inc. announced that Anne Prener, president and chief executive officer, Jai Patel, chief medical officer, and Komal Joshi, chief financial officer will participate in SVB Leerink’s Biopharma Private Company Connect, taking place virtually on March 29-31, 2022.

March 22, 2022
·
1 min read
Business

Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call

Specialty cancer diagnostics company Precipio, Inc., will be hosting its Q4-2021 and year end shareholder update call on Monday, April 4th at 5:00 PM ET.

March 22, 2022
·
3 min read
Pharm Country

Janssen Initiates First-of-its-Kind Clinical Study to Bridge Critical Gaps in Care for People of Color with Moderate to Severe Plaque Psoriasis

Psoriasis (PsO) can take a physical, psychological, and emotional toll on the more than 8 million Americans living with the disease; and for people of color, there are additional challenges due to limited medical research and education, as well as underrepresentation in clinical studies.

March 22, 2022
·
13 min read